Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

Clinical trial NCT03891784 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03891784
Sponsor: University of Washington
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Digestive System Neuroendocrine Neoplasm Digestive System Neuroendocrine Tumor Foregut Neuroendocrine Tumor Hindgut Neuroendocrine Tumor Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm Metastatic Digestive System Neuroendocrine Neoplasm Midgut Neuroendocrine Tumor Pancreatic Neuroendocrine Tumor Refractory Digestive System Neuroendocrine Neoplasm

Start date: 2019-10-31
Primary completion: 2025-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.